How bone-directed injections are given and how often

Zoledronic acid and denosumab are given in different ways, and how often you have them depends mainly on why you need them. Zoledronic acid is given as a drip into a vein, usually over about fifteen minutes or a little longer, in a day care unit. Before each dose, a blood test checks your kidney function and calcium, and you are encouraged to drink plenty of fluids. When cancer has spread to the bones, it has traditionally been given every three to four weeks. Studies have shown that for many people, giving it every twelve weeks protects bones about as well, so many teams now use the longer gap, often after an initial period. To protect bones from hormone treatment, or to lower the chance of early breast cancer returning in bone after menopause, it is usually given every six months, often for about three years. Denosumab is a small injection under the skin of the upper arm, thigh or tummy, and takes only a few seconds. For bone metastases, a higher dose is usually given every four weeks. For bone protection, a lower-dose form is given every six months. Calcium is checked before doses, especially early on, because denosumab can lower it. With both medicines, most people take daily calcium and vitamin D tablets. Your team will explain your own schedule and may adjust it over time.

Zoledronic acid is a short drip

Given in day care, with a blood test first.

Denosumab is a quick injection

Given under the skin in a few seconds.

The reason sets the schedule

Bone metastases need more frequent doses than bone protection.

Schedules are based on good evidence, but they are not rigid rules for everyone.

Less often can work as well

For many people with bone metastases, twelve-weekly zoledronic acid protects bone about as well as more frequent doses.

Stretching denosumab is still being studied

Some teams lengthen denosumab gaps after a period of treatment, but this approach is less established.

Schedules change

Kidney changes, dental problems or new treatments can alter the plan.

What this page cannot tell you

It cannot set your own schedule. Your oncologist decides it based on your situation.

Most people go home and carry on with their day.

Flu-like symptoms

After the first zoledronic acid drip, aches, fever and tiredness may appear within a day or two and usually settle within a few days. Later doses cause them less often.

Injection site

After denosumab, mild soreness or redness at the site may occur and settles quickly.

Low calcium signs

Tingling around the mouth or in the fingers, or muscle cramps, should be reported promptly.

Understanding the reasons behind your schedule makes it easier to keep to, and to spot when something needs changing.

Why this gap between doses?

Ask whether your schedule is for bone metastases or bone protection, and whether it may be stretched later.

How long will it continue?

Ask when the plan will next be reviewed and what would lead to stopping.

Who do I contact about dates?

Know who to call if you need to move an appointment, so doses are not delayed for long.